000 | 01905 a2200493 4500 | ||
---|---|---|---|
005 | 20250514010616.0 | ||
264 | 0 | _c20011011 | |
008 | 200110s 0 0 eng d | ||
022 | _a0022-5223 | ||
024 | 7 |
_a10.1067/mtc.2001.115701 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAlvarez, J M | |
245 | 0 | 0 |
_aLow-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. _h[electronic resource] |
260 |
_bThe Journal of thoracic and cardiovascular surgery _cSep 2001 |
||
300 |
_a457-63 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAprotinin _xtherapeutic use |
650 | 0 | 4 |
_aAspirin _xadverse effects |
650 | 0 | 4 |
_aBlood Component Transfusion _xstatistics & numerical data |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCoronary Artery Bypass _xadverse effects |
650 | 0 | 4 |
_aCoronary Disease _xdrug therapy |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrainage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemoglobins _xanalysis |
650 | 0 | 4 |
_aHemostatics _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMediastinum |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
650 | 0 | 4 |
_aPostoperative Care _xmethods |
650 | 0 | 4 |
_aPostoperative Hemorrhage _xblood |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aJackson, L R | |
700 | 1 | _aChatwin, C | |
700 | 1 | _aSmolich, J J | |
773 | 0 |
_tThe Journal of thoracic and cardiovascular surgery _gvol. 122 _gno. 3 _gp. 457-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1067/mtc.2001.115701 _zAvailable from publisher's website |
999 |
_c11469961 _d11469961 |